Affected Populations and Communities

Significant health disparities exist in the United States and Oregon for hepatitis B (HBV) and hepatitis C (HCV) infections, chronic liver disease, liver cancer and death in the following communities and populations:

Providers and the groups at risk may be unaware of the need to:

• Increase awareness of the existence of viral hepatitis health disparities within their communities;
• Implement effective and culturally appropriate prevention, hepatitis B vaccination and hepatitis B and C screening programs for populations and communities experiencing health disparities;
• Implement birth cohort and risk-based HCV screenings;
• Screen foreign-born Asian and Pacific Islanders and Blacks for chronic HBV infection, and
• Improve the linkages to care and treatment access for persons with chronic hepatitis B and C infection.

CONTENT NOTICE

This site contains viral hepatitis prevention messages that may not be appropriate for all audiences. Inclusion of links to external websites does not constitute Oregon Health Authority endorsement. Additional information can be found within the full Content Disclaimer.